Skip to main content
. 2022 Oct 10;9:995325. doi: 10.3389/fmed.2022.995325

Table 3.

Median survival ratios (MSRs) for 224Ra-CaCO3-MP combined with chemotherapy compared to chemotherapy as a single treatment.

Treatment (dose) Median survival combination group (days) Median survival chemotherapy only group (days) MSR
Carboplatin (60 mg/kg)-paclitaxel (10 mg/kg) and 224Ra-CaCO3-MP-2 (5 mg, 27 kBq) 103 99.5 1.0
Carboplatin (60 mg/kg)-paclitaxel (10 mg/kg) and 224Ra-CaCO3-MP-2 (5 mg, 34 kBq) 106 99.5 1.1
Carboplatin (60 mg/kg)-paclitaxel (10 mg/kg) and 224Ra-CaCO3-MP-2 (5 mg, 39 kBq) 99.5 99.5 1.0
Carboplatin (80 mg/kg)-PLD (1.6 mg/kg) and 224Ra-CaCO3-MP-2 (5 mg, 22 kBq) 113 94 1.2

PLD, pegylated liposomal doxorubicin.